AIM ImmunoTech Inc. 近日披露其关键管线进展——Duripanc 主要终点分析正式定于2026年12月启动。届时,备受市场关注的顶线结果预计将在2027年第一季度内揭晓。
AIM ImmunoTech Inc. 近日披露其关键管线进展——Duripanc 主要终点分析正式定于2026年12月启动。届时,备受市场关注的顶线结果预计将在2027年第一季度内揭晓。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.